Rick Berke, a co-founded and executive editor of STAT News, writes about the importance of its science and health care coverage.
Berke writes, “We are at a unique moment in our country’s history, when an understanding of the issues that STAT covers is more relevant than ever before — to both our personal lives and our professional lives.
“Regardless of your own politics, it’s clear that the reelection of Donald Trump is set to usher in a period of dramatic change. STAT is positioned better than any other news organization to cover what that will mean when it comes to health and medicine. It is, after all, a fundamental part of our mission to explain these issues — the nuances and implications of regulatory turns, the legislative proposals, the discussions behind closed doors at the White House, on Capitol Hill, or in the boardrooms of the top biopharma companies in the world.
“We also know Trump. Our first big story — published on our very first day of business nine years ago this week — was an investigation of his vitamin company and the bad science that was at its foundation.
“In the years since, we have continued to aggressively cover the intersection of politics and health care, and have expanded our scrutiny of biotech, pharma, science, health tech, the business of health care, and more.”
Read more here.
Dow Jones Newswires has launched its first artificial intelligence-enabled language service. The Dow Jones Korean…
Jon Delano, money and politics editor for KDKA-TV since 2001, will retire on Dec. 1.…
Bloomberg News journalist Megan Howard is joining its financial regulation team. She has been team leader for…
Hardika Singh, a markets reporter for The Wall Street Journal, has left the organization and…
Mike Bird, Asia business and finance editor for The Economist, is moving to New York…
Steven Scherer, former Ottawa bureau chief at Reuters, has left the news organization and is…